ASMR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

Comparison of agreement in the order based on the SD-TOPSIS technique across groups of combinations - B1-B5 vs. C1-C10 vs. D1-D10. by Roman Vavrek (13200141)

The NMDS plots of bacterial (A) and fungal (B) communities of the basal portion and bacterial (C) and fungal (D) communities of the apical portion based on Bray-Curits distance (n ... by Bing-Nan Zhao (21553401)

Phagocytosis of SMPs by alveolar macrophages of MH-S cell line evaluated by flow cytometry. by Alejandra Barrera-Rosales (21656278)

Combined illusion score index across conditions (NI: Non-Illusion; NIT: Non-Illusion Tactile; MS: Multisensory; UV: Unimodal Visual). by Kirralise J. Hansford (20670869)

Subjects:

Fig 6 - by Kirralise J. Hansford (20670869)

Subjects:

Fig 5 - by Kirralise J. Hansford (20670869)

Subjects:

Fig 4 - by Kirralise J. Hansford (20670869)

Subjects:

Schematic of augmented reality system with tactile stimulator. by Kirralise J. Hansford (20670869)

Subjects:

Infographic of experimental conditions. by Kirralise J. Hansford (20670869)

Subjects:

Summary of the screened symptoms at baseline (t0) for completers (n = 160). by Anton Kurapov (11346019)

Subjects:

Summary of the program evaluation. by Anton Kurapov (11346019)

Subjects:

Changes in continuous sleep measures from pre (t1) to post (t2) intervention. by Anton Kurapov (11346019)

Subjects:

Overview over the contents of the app program divided by level [28]. by Anton Kurapov (11346019)

Subjects:

Sociodemographic information, participant flow, engagement, and compliance. by Anton Kurapov (11346019)

Subjects:

Changes in mental health symptoms after the sleep intervention (n = 160 completers). by Anton Kurapov (11346019)

Subjects:

‘Sleep2Ukraine’ study design. by Anton Kurapov (11346019)

Subjects:

Density differences between pre- and post-measurements for program completers (N = 160). by Anton Kurapov (11346019)

Subjects:

Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose. by Rima Moghnieh (679199)

Subjects:

Multi-strain model fitting based on data for influenza A and B cases from the 40th week of 2023 to the 17th week of 2024 in the United States. by Shuanglin Jing (11886368)